Legal & General Group Plc - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2024$47,116
+48.4%
15,248
+23.9%
0.00%
Q1 2024$31,755
+3.2%
12,3080.0%0.00%
Q4 2023$30,771
+23.2%
12,3080.0%0.00%
Q3 2023$24,985
-22.7%
12,308
-12.4%
0.00%
Q2 2023$32,332
-12.5%
14,057
+15.2%
0.00%
Q1 2023$36,960
+30.0%
12,1980.0%0.00%
Q4 2022$28,421
+23.6%
12,1980.0%0.00%
Q3 2022$23,000
-17.9%
12,198
+16.5%
0.00%
Q2 2022$28,000
+16.7%
10,466
+31.6%
0.00%
Q1 2022$24,000
-4.0%
7,951
+21.9%
0.00%
Q4 2021$25,000
-10.7%
6,5250.0%0.00%
Q3 2021$28,000
+47.4%
6,525
+4.6%
0.00%
Q2 2021$19,000
+72.7%
6,241
+18.9%
0.00%
Q2 2019$11,000
-42.1%
5,2470.0%0.00%
Q1 2019$19,000
-82.6%
5,247
-81.5%
0.00%
Q4 2018$109,000
-53.0%
28,407
+15.8%
0.00%
Q3 2018$232,000
+510.5%
24,540
+367.7%
0.00%
Q2 2018$38,0005,2470.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2019
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$39,233,0001.19%
ARMISTICE CAPITAL, LLC 1,940,000$4,753,0001.12%
DAFNA Capital Management LLC 234,000$573,0000.50%
Alpha Wave Global, LP 1,655,162$4,055,0000.43%
Telemetry Investments, L.L.C. 150,000$368,0000.21%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,294,945$12,972,0000.18%
SABBY MANAGEMENT, LLC 792,617$1,942,0000.11%
K2 PRINCIPAL FUND, L.P. 443,887$1,088,0000.10%
Anson Funds Management LP 105,085$257,0000.08%
DIALECTIC CAPITAL MANAGEMENT, LP 25,000$61,0000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders